Shi Chanjuan, Klein Alison P, Goggins Michael, Maitra Anirban, Canto Marcia, Ali Syed, Schulick Richard, Palmisano Emily, Hruban Ralph H
Authors' Affiliations: The Sol Goldman Pancreatic Cancer Research Center and Departments of Pathology, Oncology, Medicine, and Surgery, The Johns Hopkins Medical Institutions; and Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Clin Cancer Res. 2009 Dec 15;15(24):7737-7743. doi: 10.1158/1078-0432.CCR-09-0004.
Histologic findings in 51 pancreata resected from patients with a strong family history of pancreatic cancer were compared with the findings in 40 pancreata resected from patients with sporadic pancreatic cancer. None of the patients in the familial group had a known inherited syndrome other than familial pancreatic cancer. EXPERIMENTAL DESIGN: Precursor lesions, including pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), and incipient IPMN, were quantified. Invasive cancers were classified using established histologic criteria. RESULTS: The individual precursor lesions identified in both groups were histologically similar. Precursor lesions were more common in the familial cases than in the sporadic cases. The relative rate of PanINs per square centimeter was 2.75-fold higher (95% confidence interval, 2.05-3.70; adjusted for age) in familial compared with sporadic cases. PanIN-3 lesions were more common in familial versus sporadic pancreatic cancer patients (relative rate, 4.20; 95% confidence interval, 2.22-7.93; adjusted for age). High-grade incipient IPMNs were only observed in the familial cases. Nine of the 51 (18%) familial pancreatic cancers and 4 of the 40 (10%) sporadic cancers arose in association with an IPMN. No significant differences were found in the types of invasive cancers. CONCLUSIONS: Noninvasive precursor lesions are more common in patients with a strong family history of pancreatic cancer than in patients with sporadic disease, and precursor lesions are of a higher grade in patients with a strong family history of pancreatic cancer. These findings can form a basis for the design of screening tests for the early detection of pancreatic neoplasia. (Clin Cancer Res 2009;15(24):7737-43).
将51例有胰腺癌家族病史患者切除的胰腺组织学检查结果与40例散发性胰腺癌患者切除的胰腺组织学检查结果进行比较。除家族性胰腺癌外,家族性组患者均无已知的遗传性综合征。实验设计:对包括胰腺上皮内瘤变(PanIN)、导管内乳头状黏液性肿瘤(IPMN)和早期IPMN在内的前驱病变进行定量分析。采用既定的组织学标准对浸润性癌进行分类。结果:两组中识别出的个体前驱病变在组织学上相似。前驱病变在家族性病例中比散发性病例中更常见。家族性病例每平方厘米PanIN的相对发生率比散发性病例高2.75倍(95%置信区间,2.05 - 3.70;经年龄调整)。PanIN - 3病变在家族性胰腺癌患者中比散发性患者更常见(相对发生率,4.20;95%置信区间,2.22 - 7.93;经年龄调整)。高级别早期IPMN仅在家族性病例中观察到。51例家族性胰腺癌中有9例(18%)、40例散发性癌中有4例(10%)与IPMN相关。浸润性癌的类型未发现显著差异。结论:有胰腺癌家族病史的患者中非侵袭性前驱病变比散发性疾病患者更常见,且有胰腺癌家族病史患者的前驱病变级别更高。这些发现可为早期检测胰腺肿瘤的筛查试验设计提供依据。(《临床癌症研究》2009年;15(24):7737 - 43)